← FDA Drug Approvals (Drugs@FDA)
BUSULFAN
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2020-10-23
Drug application
- FDA Application #
ANDA212127- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BUSULFAN
- Generic name
- BUSULFAN
- Active ingredients
- BUSULFAN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- MEITHEAL
- Manufacturer
- Meitheal Pharmaceuticals Inc.
- First approval
- 2020-10-23
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown